本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Tyra Biosciences, Inc.

10.34
+0.30002.99%
盤前10.30-0.0400-0.39%08:27 EDT
成交量:22.49萬
成交額:227.77萬
市值:5.49億
市盈率:-6.84
高:10.43
開:10.07
低:9.95
收:10.04
資料載入中...
2025/03/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/27

重要事件披露

Form 8-K - Current report
2025/02/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/29

重要事件披露

Form 8-K - Current report
2025/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/06

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/19

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/08

重要事件披露

Form 8-K - Current report
2024/10/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities